NO20051082L - Antimikrobielle kinoloner, deres sammensetninger og anvendelser - Google Patents

Antimikrobielle kinoloner, deres sammensetninger og anvendelser

Info

Publication number
NO20051082L
NO20051082L NO20051082A NO20051082A NO20051082L NO 20051082 L NO20051082 L NO 20051082L NO 20051082 A NO20051082 A NO 20051082A NO 20051082 A NO20051082 A NO 20051082A NO 20051082 L NO20051082 L NO 20051082L
Authority
NO
Norway
Prior art keywords
compositions
applications
antimicrobial quinolones
quinolones
antimicrobial
Prior art date
Application number
NO20051082A
Other languages
English (en)
Inventor
Benoit Ledoussal
Ji-In Kim Almstead
Jeffrey Lyle Gray
Xiufeng Eric Hu
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of NO20051082L publication Critical patent/NO20051082L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/02—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing not further condensed quinolizine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems

Abstract

Sammensetninger med følgende formel: er effektive antimikrobielle midler.
NO20051082A 2002-07-31 2005-02-28 Antimikrobielle kinoloner, deres sammensetninger og anvendelser NO20051082L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40001402P 2002-07-31 2002-07-31
PCT/US2003/022587 WO2004014893A2 (en) 2002-07-31 2003-07-18 Antimicrobial aza-bicyclic derivates, their compositions and uses

Publications (1)

Publication Number Publication Date
NO20051082L true NO20051082L (no) 2005-04-29

Family

ID=31715691

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20051082A NO20051082L (no) 2002-07-31 2005-02-28 Antimikrobielle kinoloner, deres sammensetninger og anvendelser

Country Status (17)

Country Link
US (1) US6900224B2 (no)
EP (1) EP1532137A2 (no)
JP (1) JP2005536532A (no)
KR (1) KR20050026074A (no)
CN (1) CN1671690A (no)
AU (1) AU2003259169A1 (no)
BR (1) BR0313420A (no)
CA (1) CA2493146A1 (no)
IL (1) IL166041A0 (no)
MA (1) MA27467A1 (no)
MX (1) MXPA05001180A (no)
NO (1) NO20051082L (no)
NZ (1) NZ537203A (no)
PL (1) PL375388A1 (no)
RU (1) RU2005105337A (no)
WO (1) WO2004014893A2 (no)
ZA (1) ZA200500877B (no)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69840599D1 (de) * 1997-09-15 2009-04-09 Procter & Gamble Antimikrobielle chinolone, ihre zusammensetzungen und ihre verwendungen
HU228233B1 (en) * 1999-12-28 2013-02-28 Teikoku Seiyaku Co Antipruritic agents for external use
EP1610795A4 (en) * 2003-04-07 2007-10-24 Cylene Pharmaceuticals Inc SUBSTITUTED 1,4-DIHYDRO-4-OXO-1,8-NAPHTHPYRIDINE HETEROCYCLIC ANALOGUES
KR100944600B1 (ko) * 2003-04-07 2010-02-25 사일린 파마슈티칼스, 인크 치환된 퀴노벤족사진 유사체
US7354916B2 (en) * 2003-04-07 2008-04-08 Cylene Pharmaceuticals Substituted quinobenzoxazine analogs
US7507727B2 (en) * 2003-04-07 2009-03-24 Cylene Pharmaceuticals, Inc. Substituted quinobenzoxazine analogs and methods of using thereof
US7652134B2 (en) * 2004-09-17 2010-01-26 Cylene Pharmaceuticals, Inc. Methods for converting quinolone esters into quinolone amides
WO2006034113A2 (en) * 2004-09-17 2006-03-30 Cylene Pharmaceuticals, Inc. Quinolone analogs as cell proliferation inhibitors
US7528264B2 (en) 2006-03-28 2009-05-05 The Procter & Gamble Company Hydride reduction process for preparing quinolone intermediates
KR101084521B1 (ko) 2006-03-28 2011-11-18 워너 칠콧 컴퍼니 엘엘씨 퀴놀론 중간체를 제조하기 위한 커플링 방법
AU2007230630B2 (en) * 2006-03-28 2012-12-20 Taigen Biotechnology Co., Ltd Malate salts, and polymorphs of (3S,5S)-7-[3-amino-5-methyl-piperidinyl]-1-cyclopropyl-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic acid
EP2086975B1 (en) * 2006-11-20 2012-03-14 Bristol-Myers Squibb Company 7,8-dihydro-1,6-naphthyridin-5(6h)-ones and related bicyclic compounds as inhibitors of dipeptidyl peptidase iv and methods
US8658183B2 (en) * 2007-08-09 2014-02-25 Taigen Biotechnology Company, Ltd. Antimicrobial parenteral formulation
PT3092901T (pt) 2007-10-05 2020-05-21 Senhwa Biosciences Inc Análogos de quinolona e respetivos métodos relacionados
JP2011526887A (ja) * 2008-07-01 2011-10-20 タイゲン バイオテクノロジー カンパニー，リミテッド 抗生物質耐性菌感染症の治療
CN101618039B (zh) * 2008-07-02 2012-04-11 太景生物科技股份有限公司 肺炎的治疗药物
FR2936798B1 (fr) * 2008-10-03 2012-09-28 Novexel Nouveaux composes heterocycliques azotes, leur preparation et leur utilisation comme medicaments antibacteriens.
FR2936951B1 (fr) * 2008-10-10 2010-12-03 Novexel Nouvelles combinaisons de composes heterocycliques azotes antibacteriens avec d'autres composes antibacteriens et leur utilisation comme medicaments
FR2937034B1 (fr) * 2008-10-10 2012-11-23 Novexel Nouveaux composes heterocycliques azotes, leur preparation et leur utilisation comme medicaments antibacteriens
AU2009333391B2 (en) * 2008-12-15 2013-05-02 Taigen Biotechnology Co., Ltd. Stereoselective synthesis of piperidine derivatives
CN102093260B (zh) * 2009-12-14 2014-03-05 太景生物科技股份有限公司 哌啶衍生物的立体有择合成
WO2017087235A1 (en) 2015-11-20 2017-05-26 Senhwa Biosciences, Inc. Combination therapy of tetracyclic quinolone analogs for treating cancer
US9957282B2 (en) 2015-12-14 2018-05-01 Senhwa Biosciences, Inc. Crystalline forms of quinolone analogs and their salts
WO2017107089A1 (en) 2015-12-23 2017-06-29 Merck Sharp & Dohme Corp. 3- (1h-pyrazol-4-yl) pyridineallosteric modulators of the m4 muscarinic acetylcholine receptor
WO2017112719A1 (en) 2015-12-23 2017-06-29 Merck Sharp & Dohme Corp. 6,7-dihydro-5h-pyrrolo[3,4-b]pyridin-5-one allosteric modulators of the m4 muscarinic acetylcholine receptor
WO2018112843A1 (en) 2016-12-22 2018-06-28 Merck Sharp & Dohme Corp. Heteroaryl piperidine ether allosteric modulators of the m4 muscarinic acetylcholine receptor
WO2018112840A1 (en) 2016-12-22 2018-06-28 Merck Sharp & Dohme Corp. 6, 5-fused heteroaryl piperidine ether allosteric modulators of the m4 muscarinic acetylcholine receptor
WO2018112842A1 (en) 2016-12-22 2018-06-28 Merck Sharp & Dohme Corp. 6,6-fused heteroaryl piperidine ether allosteric modulators of m4 muscarinic acetylcholine receptor
WO2019000237A1 (en) 2017-06-27 2019-01-03 Merck Sharp & Dohme Corp. ALLOSTERIC MODULATORS OF 3- (1H-PYRAZOL-4-YL) PYRIDINE FROM THE M4 ACETYLCHOLINE MUSCARINIC RECEPTOR
WO2019000238A1 (en) 2017-06-27 2019-01-03 Merck Sharp & Dohme Corp. 5- (PYRIDIN-3-YL) OXAZOLE ALLOSTERIC MODULATORS OF M4 ACETYLCHOLINE MUSCARINIC RECEPTOR
WO2019000236A1 (en) 2017-06-27 2019-01-03 Merck Sharp & Dohme Corp. ALLOSTERIC MODULATORS OF 3- (1H-PYRAZOL-4-YL) PYRIDINE FROM THE M4 ACETYLCHOLINE MUSCARINIC RECEPTOR
TW202000195A (zh) 2018-02-15 2020-01-01 生華生物科技股份有限公司 喹啉酮類似物及其鹽、組合物及其使用方法
CA3098060A1 (en) 2018-04-25 2019-10-31 Bayer Animal Health Gmbh Process for the hydrolysis of quinolone carboxylic esters

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE117685T1 (de) 1988-05-19 1995-02-15 Chugai Pharmaceutical Co Ltd Chinoloncarbonsäure-derivate.
DE69430581D1 (de) * 1993-10-14 2002-06-13 Abbott Lab Verbindungen des chinolizinon-typs
EP0871628A1 (en) * 1995-06-06 1998-10-21 Abbott Laboratories Quinolizinone type compounds
KR100241673B1 (ko) * 1997-08-09 2000-03-02 김충섭 퀴놀리진 카르복실산 유도체
US6387928B1 (en) 1997-09-15 2002-05-14 The Procter & Gamble Co. Antimicrobial quinolones, their compositions and uses
DE69840599D1 (de) * 1997-09-15 2009-04-09 Procter & Gamble Antimikrobielle chinolone, ihre zusammensetzungen und ihre verwendungen
GB9822440D0 (en) 1998-10-14 1998-12-09 Smithkline Beecham Plc Medicaments
GB9914486D0 (en) 1999-06-21 1999-08-18 Smithkline Beecham Plc Medicaments
EE200200412A (et) * 2000-01-24 2003-10-15 Warner-Lambert Company 3-aminokinasoliin-2,4-dioon kui antibakteriaalne agens
WO2002048138A1 (en) 2000-12-14 2002-06-20 The Procter & Gamble Company Antimicrobial quinolones

Also Published As

Publication number Publication date
KR20050026074A (ko) 2005-03-14
MA27467A1 (fr) 2005-08-01
WO2004014893A3 (en) 2004-04-08
WO2004014893A2 (en) 2004-02-19
NZ537203A (en) 2007-02-23
ZA200500877B (en) 2006-02-20
BR0313420A (pt) 2005-06-28
JP2005536532A (ja) 2005-12-02
RU2005105337A (ru) 2006-01-20
CN1671690A (zh) 2005-09-21
US6900224B2 (en) 2005-05-31
EP1532137A2 (en) 2005-05-25
PL375388A1 (en) 2005-11-28
CA2493146A1 (en) 2004-02-19
IL166041A0 (en) 2006-01-15
AU2003259169A1 (en) 2004-02-25
US20040038975A1 (en) 2004-02-26
MXPA05001180A (es) 2005-05-16

Similar Documents

Publication Publication Date Title
NO20051082L (no) Antimikrobielle kinoloner, deres sammensetninger og anvendelser
CY1106958T1 (el) Ν-αλκυλο-4-μεθυλεναμινο-3-υδροξυ-2-πυριδονες ως αντιμικροβιακα
IS7721A (is) Píperidín-pýrídasón og þalasón sem PDE4 hemlar
NO20062892L (no) 7-fenylalkyl-substituert 2-kinolinoner og 2-kinoksalinoner som poly(adp-ribose)-polymeraseinhibitorer
SE0102315D0 (sv) Compounds
NO20044995L (no) Heterosykliske forbindelser
DK1432705T3 (da) Antibiotika med dobbeltvirkning
NO331012B1 (no) N-sulfonyl-4-metylenamino-3-hydroksy-2-pyridoner som antimikrobielle midler
NO20064415L (no) Nye amido-substituerte hydroksy-6-fenylfenantridiner og deres anvendelse som PDE4-inhibitorer
RS50629B (sr) Amidni prolek gemcitabina, kompozicije i njihova primena
EA200801351A1 (ru) Фунгицидные смеси, которые содержат боскалид и пириметанил
ATE511352T1 (de) Antimikrobielle zusammensetzungen
DK1709044T4 (da) Oxazolidinon-quinolon-hybridantibiotika
NO20080265L (no) 2-(1H-indolylsulfanyl)-arylaminderivater
DE60321594D1 (de) Synergistische zusammensetzungen
DK1644385T3 (da) Siliciumforbindelser og deres anvendelse
DK1095059T3 (da) Kemotaksi-hæmmende protein af staphylococcus (chips) og dets anvendelse
NO20053562L (no) Nye aminobenzofenonforbindelser
NO20030500D0 (no) Dihydroporfyrinderivater og deres anvendelse
BR0313400A (pt) N-aril-2-oxazolidinonas e seus derivados
DK1648906T3 (da) Organo-silicium-forbindelser og deres anvendelse
ATE364037T1 (de) Tryptasehemmer
UY27311A1 (es) Agentes antibacterianos
PT1358182E (pt) Derivados de diazocinas e sua utilizacao como inibidores de triptase

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application